15001 Durable efficacy of certolizumab pegol dosed at 400...

Journal of the American Academy of Dermatology 2020 / 12 Vol. 83; Iss. 6

15001 Durable efficacy of certolizumab pegol dosed at 400 mg every two weeks over 128 weeks in patients with plaque psoriasis enrolled in three phase 3 trials (CIMPASI-1, CIMPASI-2, and CIMPACT)

Gordon, Ken, Warren, Richard B., Gottlieb, Alice B., Blauvelt, Andrew, Thaci, Diamant, Poulin, Yves, Boehnlein, Marion, Brock, Fiona, Arendt, Catherine, Reich, Kristian
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
83
Journal:
Journal of the American Academy of Dermatology
DOI:
10.1016/j.jaad.2020.06.643
Date:
December, 2020
File:
PDF, 78 KB
2020
Conversion to is in progress
Conversion to is failed